Tevogen Bio Holdings Inc. ( TVGN) - Key Metrics
TVGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.50 | -$0.78 | -$0.78 |
| 2026Q1 | $0 | -$1.56 | -$0.78 | -$0.78 |
| 2025Q4 | $0 | -$1.41 | -$0.66 | -$0.68 |
| 2025Q3 | $0 | -$1.46 | -$0.93 | -$0.93 |
| 2025Q2 | $0 | -$1.49 | -$0.87 | -$0.87 |
TVGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.93 |
| 2026Q1 | 0% | -0.70 |
| 2025Q4 | 0% | -3.45 |
| 2025Q3 | 0% | -6.55 |
| 2025Q2 | 0% | -10.21 |
TVGN
Price: $6.65
52 week price:
Earnings Per Share: -6.29 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 26.6 million